Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

HBIO Harvard Bioscience Inc
$4.74 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy HBIO stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 21.0M
Enterprise value 238.4M
Trailing PE -1.6857142959322
Forward PE 5.9187503
PEG Ratio 0.023178571569068
Enterprise to EBITDA 39.635
Enterprise to revenue 2.755
Price to book MRQ 1.5373377
Price to sales TTM 0.24170054

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 86.6M
EBITDA 294.0K
Diluted EPS TTM -1.28
Total Cash (MRQ) 8.6M
Current ratio (MRQ) 2.196
Operating Cash Flow (TTM) 6.7M

HBIO trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent HBIO News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.